Screening for compensated advanced chronic liver disease using transient elastography in outpatient addiction clinics.

ABSTRACT:

Background

Patients with substance use disorders present with many risk factors for liver disease-including alcohol, hepatitis C virus infection, and obesity-and should thus be screened for compensated advanced chronic liver disease (cACLD). Such screening could potentially be performed by outpatient addiction clinics. In this study, we aimed to assess the feasibility, acceptability, and results of cACLD screening using transient elastography (TE) among all patients attending routine follow-up visits at addiction clinics, regardless of their liver disease risk factors.

Methods

Liver fibrosis evaluation using TE was offered to every patient consulting two different addiction clinics in France, between December 2020 and September 2021, during dedicated half-day screening sessi

SUBMITTER: Karrer A 

PROVIDER: S-EPMC11629458 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature